Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Peab in connection with the listing of Annehem Fastigheter
Mandate

Vinge has advised Peab in connection with the listing of Annehem Fastigheter

December 11, 2020 Banking and Finance Capital Markets and Public M&A Corporate Tax Real Estate and Construction

Vinge has advised Peab and Annehem Fastigheter in connection with the distribution of the shares in Annehem Fastigheter to the shareholders in Peab as well as the listing of Annehem Fastigheter’s B shares on Nasdaq Stockholm. The prospectus was published 2 December 2020 and the first day of trading on Nasdaq Stockholm was 11 December 2020.

Annehem Fastigheter is a growth-driven property company specialising in commercial, community service and residential properties in the Nordic growth regions of Stockholm, Skåne, Gothenburg as well as Helsinki and Oslo. Annehem Fastigheter’s property portfolio consists of 22 investment properties with a value of SEK 3,281 million and a lettable area of 184 thousand sqm.

Vinge’s team consisted of Charlotte Levin, Rikard Lindahl, Joel Magnusson, Linnea Petersson, Assur Badur, Kristoffer Larson, Vilhelm Rondahl, Louise Brorsson Salomon, Linn Adelwald, Henrik Wastenson and Victor Ericsson.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025